Literature DB >> 159130

Interaction of int protein with specific sites on lambda att DNA.

W Ross, A Landy, Y Kikuchi, H Nash.   

Abstract

We have studied the interaction of highly purified Int protein with DNA restriction fragments from the lambda phage attachment site (attP) region. Two different DNA sequences are protected by bound Int protein against partial digestion by either pancreatic DNAase or neocarzinostatin. One Int binding site includes the 15 bp common core sequence (the crossover region for site-specific recombination) plus several bases of sequence adjoining the core in both the P and P' arms. The second Int-protected site occurs 70 bp to the right of the common core in the P' arm, just at the distal end of the sequence encoding Int protein. The two Int binding sites are of comparable size, 30-35 bp, but do not share any extensive sequence homology. The interaction of Int with the two sites is distinctly different, as defined by the observation that only the site in the P' arm and not the site at the common core region is protected by Int in the face of challenge by the polyanion heparin. Restriction fragments containing DNA from the bacterial attachment site (attB) region exhibit a different pattern of interaction with Int. In the absence of heparin, a smaller (15 bp) sequence, which includes the left half of the common core region and the common core-B arm juncture, is protected against nuclease digestion by Int protein. No sequences from this region are protected by Int in the presence of heparin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159130      PMCID: PMC1931615          DOI: 10.1016/0092-8674(79)90049-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  Structure of nucleosome core particles of chromatin.

Authors:  J T Finch; L C Lutter; D Rhodes; R S Brown; B Rushton; M Levitt; A Klug
Journal:  Nature       Date:  1977-09-01       Impact factor: 49.962

2.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

3.  Viral integration and excision: structure of the lambda att sites.

Authors:  A Landy; W Ross
Journal:  Science       Date:  1977-09-16       Impact factor: 47.728

Review 4.  Integration and excision of bacteriophage lambda.

Authors:  H A Nash
Journal:  Curr Top Microbiol Immunol       Date:  1977       Impact factor: 4.291

5.  Deletion mutants of bacteriophage lambda. II. Genetic properties of att-defective mutants.

Authors:  J S Parkinson
Journal:  J Mol Biol       Date:  1971-03-14       Impact factor: 5.469

6.  The cleavage site of the restriction endonuclease Ava II.

Authors:  J G Sutcliffe; G M Church
Journal:  Nucleic Acids Res       Date:  1978-07       Impact factor: 16.971

7.  Binding of Escherichia coli RNA polymerase to T7 DNA. Displacement of holoenzyme from promoter complexes by heparin.

Authors:  S R Pfeffer; S J Stahl; M J Chamberlin
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

8.  The specificity of five DNAases as studied by the analysis of 5'-terminal doublets.

Authors:  A Bernardi; C Gaillard; G Bernardi
Journal:  Eur J Biochem       Date:  1975-04-01

9.  A restriction enzyme Tha I from the thermophilic mycoplasma Thermoplasma acidophilum.

Authors:  D J McConnell; D G Searcy; J G Sutcliffe
Journal:  Nucleic Acids Res       Date:  1978-06       Impact factor: 16.971

10.  Characterization of the integration protein of bacteriophage lambda as a site-specific DNA-binding protein.

Authors:  M Kotewicz; S Chung; Y Takeda; H Echols
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

View more
  39 in total

1.  The small DNA binding domain of lambda integrase is a context-sensitive modulator of recombinase functions.

Authors:  D Sarkar; M Radman-Livaja; A Landy
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

2.  CTnDOT integrase interactions with attachment site DNA and control of directionality of the recombination reaction.

Authors:  Margaret M Wood; Jeanne M Dichiara; Sumiko Yoneji; Jeffrey F Gardner
Journal:  J Bacteriol       Date:  2010-05-28       Impact factor: 3.490

3.  Resolution of Holliday junction recombination intermediates by wild-type and mutant IntDOT proteins.

Authors:  Seyeun Kim; Jeffrey F Gardner
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

4.  A structural basis for allosteric control of DNA recombination by lambda integrase.

Authors:  Tapan Biswas; Hideki Aihara; Marta Radman-Livaja; David Filman; Arthur Landy; Tom Ellenberger
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

5.  Studies on the binding of lambda Int protein to attachment site DNA: identification of a tight-binding site in the P' region.

Authors:  R W Davies; P H Schreier; M L Kotewicz; H Echols
Journal:  Nucleic Acids Res       Date:  1979-12-20       Impact factor: 16.971

6.  IntDOT interactions with core- and arm-type sites of the conjugative transposon CTnDOT.

Authors:  Jeanne M Dichiara; Aras N Mattis; Jeffrey F Gardner
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

7.  I-TevI, the endonuclease encoded by the mobile td intron, recognizes binding and cleavage domains on its DNA target.

Authors:  D Bell-Pedersen; S M Quirk; M Bryk; M Belfort
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Interactions of NBU1 IntN1 and Orf2x proteins with attachment site DNA.

Authors:  Margaret M Wood; Lara Rajeev; Jeffrey F Gardner
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

9.  Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides.

Authors:  R M Gronostajski
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

10.  Replication of pSC101: effects of mutations in the E. coli DNA binding protein IHF.

Authors:  P Gamas; A C Burger; G Churchward; L Caro; D Galas; M Chandler
Journal:  Mol Gen Genet       Date:  1986-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.